Compare ELWT & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELWT | NTRB |
|---|---|---|
| Founded | 2002 | 2016 |
| Country | United States | United States |
| Employees | 34 | 3 |
| Industry | Telecommunications Equipment | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.6M | 44.2M |
| IPO Year | N/A | N/A |
| Metric | ELWT | NTRB |
|---|---|---|
| Price | $6.12 | $4.06 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 39.7K | 9.3K |
| Earning Date | 05-15-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $167.76 | $30.17 |
| Revenue Next Year | $22.42 | $3,394.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.11 | $3.42 |
| 52 Week High | $8.25 | $11.68 |
| Indicator | ELWT | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 50.22 | 50.49 |
| Support Level | $6.30 | $3.51 |
| Resistance Level | $7.10 | $4.50 |
| Average True Range (ATR) | 0.71 | 0.26 |
| MACD | -0.04 | 0.05 |
| Stochastic Oscillator | 58.26 | 68.09 |
Elauwit Connection Inc is a provider of broadband Internet networks for the multifamily and student housing property sector. It designs, installs, operates, and maintains new fiber-optic and WiFi networks throughout each contracted property. Once installed, property owners begin selling Internet connectivity over Elauwit's network directly to their residents at monthly prices and terms of their choosing. Elauwit, in turn, provides all resident activation, onboarding, customer support, and network monitoring and maintenance services in exchange for a fixed monthly fee based on the number of units in the property times a monthly per-unit wholesale price. Its contracts with property owners generally have five to eight-year terms. Geographically, the company mainly operates in the U.S.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.